Trial Summary
What is the purpose of this trial?This trial tests a device that monitors muscle activity to detect seizures in veterans with arm-involved motor seizures. The device alerts users when it detects unusual muscle movements, helping to identify seizures.
Eligibility Criteria
This trial is for veterans aged 22-99 with a history of motor seizures, who can consent to the study and commit to using the SPEAC System for up to 120 days. They must be able to follow procedures and use the system for at least 30 hours per week. It's not open to those in other trials, pregnant or nursing women, individuals allergic to adhesives or tapes, or without home power supply.Inclusion Criteria
I have tried less than 3 epilepsy medications without success.
I or my caregiver can follow all study instructions.
I am a veteran with a history of seizures affecting my arms, and my seizure type is unclear.
+4 more
Exclusion Criteria
The subject cannot be pregnant, or nursing.
The subject may not be enrolled in another Clinical Trial.
The subject cannot be sensitive or allergic to adhesives or tapes.
+1 more
Participant Groups
The SPEAC System is being tested; it's an sEMG-based seizure monitoring device that alerts users about convulsive seizures. This study aims to see how this technology affects healthcare decisions and management for veterans with epilepsy in their homes.
2Treatment groups
Experimental Treatment
Active Control
Group I: Treatment GroupExperimental Treatment1 Intervention
SPEAC System
Group II: Standard of CareActive Control1 Intervention
Standard of Care
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Lexington VA Medical CenterLexington, KY
Loading ...
Who Is Running the Clinical Trial?
Brain SentinelLead Sponsor